Trulicity subcutaneous injection 0.75mg Ateos

Trulicity subcutaneous injection 0.75mg Ateos (YJ code: 2499416G1029, standard: 0.75mg x 0.5mL x 1 kit), manufactured by Eli Lilly Japan, contains dulaglutide (genetical recombination). This once-weekly GLP-1 receptor agonist is used with diet and exercise to improve blood sugar in adults and children 10 years and older with type 2 diabetes, and to reduce the risk of major cardiovascular events.